Skip to main content

Part of the book series: Current Histopathology ((CUHI,volume 9))

  • 229 Accesses

Abstract

Many different myopathies probably result from a metabolic disturbance in the muscle cell. At present the biochemical events responsible for changes, such as the abnormal permeability of the cell membrane in Duchenne dystrophy, are unknown. The mode of action of various drugs and hormones is not well defined. There is, however, a sizeable group of myopathies where a fundamental biochemical defect, often a specific enzyme deficiency, has been identified. These disorders can justifiably be referred to as metabolic myopathies. Undoubtedly there will be many additions as further biochemical lesions are detected.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Morgan-Hughes, J. A. (1982). Defects of the energy pathways of skeletal muscle. In Matthews, W. B. and Glaser, G. H. (eds.) Recent Advances in Clinical Neurology, pp. 1–46. (Edinburgh: Churchill Livingstone)

    Google Scholar 

  2. Gollnick, P. D., Piehl, K. and Saltin, B. (1974). Selective glycogen depletion pattern in human muscle fibres after exercise of varying intensity and at varying pedalling rates. J. Physiol. (London), 241, 45–57

    PubMed  CAS  Google Scholar 

  3. Feit, H. and Brooke, M.H. (1976). Myophosphorylase deficiency: two different molecular etiologies. Neurology, 26, 963–7

    PubMed  CAS  Google Scholar 

  4. Bonilla, E. and Schotland, D. L. (1970). Histochemical diagnosis of muscle phosphofrucktokinase deficiency. Arch. Neurol., 22, 8–12

    PubMed  CAS  Google Scholar 

  5. DiMauro, S. (1979). Metabolic myopathies. In Vinken, P. J. and Bruyn, G.W. (eds.) Handbook of Clinical Neurology, 41. pp. 175–224. (Amsterdam: North Holland)

    Google Scholar 

  6. Engel, A. G., Gomez, M. R., Seybold, M. E. and Lambert, E. H. (1973). Spectrum and diagnosis of acid maltase deficiency. Neurology, 23, 95–106

    PubMed  CAS  Google Scholar 

  7. Fensom, A. H., Benson, P. F., Blunt, S., Brown, S. P. and Coltart, T.M. (1976). Amniotic cell 4-methylumbelliferyl-alpha- glucosidase activity in prenatal diagnosis of Pompe’s disease. J. Med. Genet., 13, 148–51

    Article  PubMed  CAS  Google Scholar 

  8. Hudgson, P. and Fulthorpe, J.J. (1975). The pathology of type 2 skeletal muscle glycogenosis. J. Pathol., 116, 139–47

    Article  PubMed  CAS  Google Scholar 

  9. Karpati, G. et al. (1977). The adult form of acid maltase deficiency. Ann. Neurol., 1, 276–80

    Article  PubMed  CAS  Google Scholar 

  10. Papapetroupoulos, T., Paschalis, C. and Manda, P. (1984). Myopathy due to juvenile acid maltase deficiency affecting exclusively the type I fibres. J. Neurol. Neurosurg. Psychiatry, 47, 213–15

    Google Scholar 

  11. Shanske, S. and DiMauro, S. (1981). Late onset acid maltase deficiency. J. Neurol. Sci., 50, 57–62

    Article  PubMed  CAS  Google Scholar 

  12. Huijing, F. (1975). Glycogen metabolism and glycogen storage disease. Physiol. Rev., 55, 609–58

    PubMed  CAS  Google Scholar 

  13. Cornelio, F., Bresolin, N., Singer, P.A., Di Mauro, S. and Rowland, L. P. (1984). Clinical varieties of Neuromuscular Disease in Debrancher Deficiency. Arch. Neurol., 41, 1027–32

    Google Scholar 

  14. DiMauro, S., Dalakas, M. and Miranda, A. F. (1981). Phosphoglycerate kinase deficiency: a new cause of recurrent myoglobinuria. Ann. Neurol., 10, 90

    Google Scholar 

  15. Keleman, J. et al. (1982). Familial myoadenylate deaminase deficiency and exertional myalgia. Neurology, 32, 857–63

    Google Scholar 

  16. Prince, F. P. et al. (1981). A morphometric analysis of human muscle fibres with relation to fibre types and adaptation to exercise. J. Neurol. Sci., 49, 165–79

    Article  PubMed  CAS  Google Scholar 

  17. Willner, J. H. etal. (1979). Muscle carnitine deficiency: genetic heterogeneity. J. Neurol. Sci., 41, 235–46

    Article  PubMed  CAS  Google Scholar 

  18. Van Dyke, D. H. Griggs, R. C., Markesbery, W. and DiMauro, S. (1979). Hereditary carnitine deficiency of muscle. Neurology, 25, 154–9

    Google Scholar 

  19. Hart, Z. H. et al. (1978). Muscle carnitine deficiency and fatal cardiomyopathy. Neurology, 28, 147–51

    PubMed  CAS  Google Scholar 

  20. Angelini, C., Lucke, S. and Cantarutti, F. (1976). Carnitine deficiency of muscle: report of a treated case. Neurology, 26, 633–7

    PubMed  CAS  Google Scholar 

  21. Hosking, G. P., Cavanagh, N. P. C. Smyth, D. P. L. and Wilson, J. (1977). Oral treatment of carnitine myopathy. Lancet, 1, 853

    Article  PubMed  CAS  Google Scholar 

  22. Bourdin, G., Mikol, J., Guillard, A. and Engel, A. G. (1976). Fatal systemic carnitine deficiency with lipid storage in skeletal muscle, heart, liver and kidney. J. Neurol. Sci., 30, 313–25

    Article  Google Scholar 

  23. DiDonato, S. et al. (1981). Heterogeneity of carnitine palmitoyl transferase deficiency. J. Neurol. Sci., 50, 207–15

    Article  CAS  Google Scholar 

  24. Cumming, W. J. K., Hardy, M., Hudgson, P. and Wells, J. (1976). Carnitine palmitoyl transferase deficiency. J. Neurol. Sci., 30, 247–58

    Article  PubMed  CAS  Google Scholar 

  25. DiMauro, S. et al. (1980). Fatal infantile mitochondrial myopathy and renal dysfunction due to cytochrome C oxidase deficiency. Neurology, 30, 795–804

    PubMed  CAS  Google Scholar 

  26. Morgan-Hughes, J. A. et al. (1977). A mitochondrial myopathy characterised by deficiency in reducible cytochrome b. Brain, 100, 617–40

    Article  PubMed  CAS  Google Scholar 

  27. Morgan-Hughes, J. A. et al. (1979). A mitochondrial myopathy with deficiency of respiratory chain NADH-CoQ reductase activity. J. Neurol. Sci., 43, 27–46

    Article  PubMed  CAS  Google Scholar 

  28. Morgan-Hughes, J. A. et al. (1982). Mitochondrial encephalo-myopathies. Biochemical studies in 2 cases revealing defects in the respiratory chain. Brain, 105, 553–82

    Article  PubMed  Google Scholar 

  29. Hayes, D.J., Lecky, B.R.F., Landon, D.N., Morgan-Hughes, J. A. and Clark, J. B. (1984). A new mitochondrial myopathy. Biochemical studies revealing a deficiency in the cytochrome b-c-1, complex (complex III) of the respiratory chain. Brain, 107, 1165–77

    Article  PubMed  Google Scholar 

  30. Johnson, M. A., Turnbull, D.M., Dick, D.J. and Sherratt, H. S. A. (1983). A partial deficiency of cytochrome C oxidase in chronic progressive external ophthalmoplegia. J. Neurol. Sci., 60, 31–53

    Article  PubMed  CAS  Google Scholar 

  31. Tassin, S. and Brucher, J.M. (1982). The mitochondrial disorders: pathogenesis and aetiological classification. Neuropathol. Appl. Neurobiol., 8, 251–63

    Article  PubMed  CAS  Google Scholar 

  32. Swash, M., Schwartz, M. S. and Seargeant, M. K. (1978). The significance of ragged red fibres in neuromuscular disease. J. Neurol. Sci., 38, 347–355

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Janice R. Anderson

About this chapter

Cite this chapter

Anderson, J.R. (1985). Metabolic Myopathies. In: Atlas of Skeletal Muscle Pathology. Current Histopathology, vol 9. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4866-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4866-2_15

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8653-0

  • Online ISBN: 978-94-009-4866-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics